Marenco CCA, Del Vecchyo CC

Language: Spanish
References: 14
Page: 121-125
PDF size: 156.03 Kb.

ABSTRACT

The use of the amniotic membrane as a temporary biological cover facilitates the epithelialization in burns of partial thickness, diminishes the pain when isolating the injuries and by the presence of anti-inflammatory factors. Radio-sterilized amniotic membrane was applied in 15 patients, who were cured in a period of 21 days in areas where was not used the biological dressing and 10 ± 3 in where the membrane was applied. The amnion works like a barrier between the wound and the environment, since it reduces the feeling of pain, reduces electrolytes and protein heat loss; helps to achieve a fast epithelialization in burns of partial thickness and prepares the total thickness wound to be covered with grafts. The time that goes by elapses for the treatment of burns of partial thickness is reduced with the application of the amniotic membrane, which was statistically one demonstrated.

REFERENCES

1. Sawhney CP. Amniotic membrane as a biological dressing in the management of burns. Burns 1989; 15(5): 339-42.

2. Polzin WJ, Lockrow EG, Morishige WK. A pilot study identifying type V collagenolytic activity in human amniotic fluid. Am J Perinatol 1997; 14: 103-106.

3. Van Herendael BJ, Oberti C, Brosens I. Microanatomy of the human amniotic membranes. A light microscopic, transmission, and scanning electron microscopic study. Am J Obstet Gynecol 1978; 131: 872-880.

4. Sippel Kimberly C. Amniotic membrane surgery. Current opinion in Ophthalmology 2001; 12(4): 269-281.

5. Koizumi N, Fullwood NJ, Bairaktaris G et al. Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane. Invest Ophthalmol Vis Sci 2000; 41: 2506-2513.

6. Sistani F, Erb C, Brockmann D et al. Human amniotic membrane after different cryopreservation methods. Invest Ophthalmol Vis Sci 2001; 42: S269.

7. Noda Y, Kaji Y, Hori J et al. Amniotic membrane confers immune privilege on corneal allografts when placed at a non-privileged site. Invest Ophthalmol Vis Sci 2001; 42: S473.

8. Choi, Tae Hoon. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea 2001; 20(4): 408-413.

9. Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells. Nature 1982; 295: 325.

10. Klein CE, Dressel D, Steinmayer T et al. Integrin [alpha] 2[beta]1 is up-regulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J Cell Biol 1991; 115: 1427-1436.

11. Khodadoust AA, Silverstein AM, Kenyon DR et al. Adhesion of regenerating corneal epithelium. The role of basement membrane. Am J Ophthalmol 1968; 65: 339-348.

12. Fukuda K, Chikama T, Nakamura M, Nishida T. Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva. Cornea 1999; 18: 73-79.

13. Boudreau N, Sympson CJ, Werb Z et al. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995; 267: 891-893.

14. Hurme M, Lahdenpohja N, Santtila S. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med 1998; 30: 469-73.